Zentalis Pharmaceuticals, Inc. · NASDAQ:ZNTL

Matrix Capital Management Company, LP reported a 9.98% stake in Zentalis Pharmaceuticals, Inc. (Schedule 13D/A)

Event Dec 15, 2025 · Filed Dec 15, 2025

Matrix Capital Management Company, LP reported a 9.98% stake in Zentalis Pharmaceuticals, Inc., 6,459,973 shares, with active intent on Dec 15, 2025. Filed Dec 15, 2025 (Schedule 13D/A).

Stake
9.98%
Shares
6,459,973
Intent
Active
What changed
Stake changed
Filed together
2 holders

The filing in full

HolderStakeShares
Matrix Capital Management Company, LP9.98%6,459,973
David E. Goel9.98%6,459,973

Source

View original at SEC

Related